Conversely, the upregulation of proteins such as HGF and CCL19, along with increased inflammatory cytokines like IL-6, CXCL10, and CCL8, suggests an inflammatory environment that could predispose OBO individuals to the development of a metabolic syndrome [22]. The gene discussed is CCL19; the disease is metabolic syndrome.